Deep Tech Startups
7,090 companies tagged Deep Tech, with their investors and founders.
ProteoNova is a biotechnology company developing proprietary technology for protein-related applications, led by founders with extensive biotech and medical research expertise.
0 investors
Providence Photonics develops optical gas imaging technology, computer vision, and infrared imagers for industrial gas leak detection, leak quantification, and flare combustion monitoring. Its products serve industries and regulators addressing environmental and safety compliance, including EPA-approved flare monitoring and autonomous methane leak detection systems.
0 investors
Pure Scientific Technologies Inc. is a company presenting investor relations contact information on its site. The page does not describe the company's actual products or business activities.
0 investors
Pylum Bio is a biotechnology company developing therapeutics, drawing on microbiology, immunology, and molecular genetics research. Its leadership includes founders and directors with backgrounds in pharmaceutical R&D and life sciences.
0 investors
Pyronexus provides integrated, turnkey project development services for biochar production facilities, managing feasibility studies through commissioning and ongoing operations. The company serves project developers and operators in the biochar and biomass processing sector.
0 investors
Quantasonix builds inline, non-destructive sensing and analytics systems that continuously measure the physical properties of industrial fluids during operation, delivering real-time interpreted physical-state data. It serves organizations in advanced industrial environments and federal agencies.
0 investors
Quantum Catalyzer (Q-Cat) is a deep tech venture builder that turns quantum research into commercial technologies and startups, working with government and industry partners. Its first product is the Quantum Diamond Microscope for wide-field magnetic field imaging, now sold through its portfolio company EuQlid.
0 investors
Quantum Corridor operates a quantum-ready fiber network offering quantum-safe connectivity, precision timing, and quantum compute access for enterprises, universities, data centers, and government agencies. Founded in 2022, it runs across the Chicago and Northwest Indiana corridor with sites in Hammond (IN), Chicago, and Naperville (IL).
0 investors
Quantum Formatics develops AI-driven methods to accelerate the discovery and design of next-generation superconductors for fusion energy and electrification applications. The company combines machine learning with materials science to enable faster innovation in superconducting materials.
0 investors
Quantum Technology Sciences designs and manufactures geophysical technology using seismic-acoustic sensors to provide real-time situational awareness for border security, critical infrastructure protection, and military defense applications. The company serves U.S. Federal agencies including the Department of Defense, Department of Homeland Security, and Department of Energy.
0 investors
Qureator develops non-animal testing methods for drug development, notably achieving an FDA IND approval without animal proof-of-concept data in collaboration with SillaJen. The company works in preclinical biotech, providing alternatives to animal testing for pharmaceutical partners.
0 investors
Qwerky offers a proprietary optimization process and hardware-agnostic technology that makes AI models run faster with lower VRAM and compute requirements, cutting infrastructure costs. It licenses optimized open-source models, builds custom solutions, and offers ready-made AI products for enterprises to run on edge devices, cloud, or on-premises.
0 investors
Rampart Communications develops secure wireless communication technology based on Unitary Braid Division Multiplexing (UBDM), a signal processing and information theory approach to communications security. It holds patents and partners with organizations across industries to build secure wireless systems for individuals, businesses, and governments.
0 investors
Rare Earth Technologies, Inc. (RETi) refines and separates rare-earth elements using a proprietary column-chemistry system that produces oxides or carbonates at up to 99.999% purity with non-toxic solvents. The company serves the REE materials supply chain and plans to open its first US refining facility in 2025.
0 investors
Red Leader develops signal processing IP, integrated ADC/DAC silicon, and end-to-end systems for 3D lidar sensing, using full-waveform processing to improve resolution, range, and accuracy of low-cost sensors without added hardware. Its technology targets safety-critical applications requiring high-speed, low-latency 3D data.
0 investors
Red Team Investments (RTI) is an investment firm that applies a "Red Team" adversarial evaluation approach to identify macro market trends and investment opportunities, drawing on experience across the energy, data, technology, and investment sectors. The firm also plans to build regional data centers to provide AI compute and data storage for its portfolio companies and customers.
0 investors
RedactBio is a biotechnology company working at the intersection of gene editing and tissue engineering.
0 investors
ReElement develops purification and separation technology for refining critical minerals into high-purity materials at low cost. The company operates globally with a focus on deploying its technology platform in mineral-rich African nations to support local advanced manufacturing.
0 investors
RenBio develops DNA-based therapeutic technology that uses intramuscular injection of therapeutic-encoding "bioblueprints" so a patient's own muscle cells produce antibodies and therapeutic proteins to prevent and treat diseases, including infectious diseases. The company works in the antibody and therapeutic protein field, aiming to overcome obstacles in delivery, durability, and cost.
0 investors
Renerva develops implantable medical devices to treat peripheral nerve injuries. The company was founded from academic research at the University of Pittsburgh and Cornell University.
0 investors
Replicate Bioscience develops self-replicating RNA (srRNA) vector therapeutics that use cells' own machinery to produce sustained protein expression, aiming for durable therapeutic effects. Its pipeline targets several therapeutic areas including infectious disease, oncology, and autoimmune disorders.
0 investors
Revel Pharmaceuticals develops enzyme-based therapeutics designed to recognize and reverse molecular damage that accumulates in the body's structural tissue — collagen, elastin, and extracellular matrix — targeting age-related damage that drives disease. The company screens natural enzyme variants against real substrates to identify and engineer them into treatments.
0 investors
Reverse Ionizer develops patented water treatment technologies for commercial and industrial applications. Its Plasma Disinfection System uses non-thermal plasma to control pathogens in cooling towers and water systems, while its electromagnetic ExB technology addresses scale and corrosion in desalination plants.
0 investors
Revitope Oncology is a biotechnology company developing precision cancer immunotherapies using its TwoGATE T cell engager platform, which uses paired tumor-targeted bispecific antibodies that become active only on cancer cells co-expressing two antigens to limit toxicity to healthy tissue. Its pipeline focuses on solid tumor indications, developed in-house and through partnerships with companies such as Genmab and Junshi Biosciences.
0 investors